Healthpeak Properties, Inc. (DOC)
Healthpeak (DOC) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Healthpeak (DOC) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Healthpeak (DOC) Q2 FFO Meet Estimates
Healthpeak (DOC) came out with quarterly funds from operations (FFO) of $0.46 per share, in line with the Zacks Consensus Estimate . This compares to FFO of $0.45 per share a year ago.
What's in the Cards for Healthpeak Properties This Earnings Season?
DOC's Q2 earnings are likely to benefit from rising healthcare spending and the aging population. However, higher interest expenses may have hurt it.
Healthpeak (DOC) Q2 Earnings Preview: What You Should Know Beyond the Headline Estimates
Get a deeper insight into the potential performance of Healthpeak (DOC) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Healthpeak's Valuation Disconnect: Strong Assets, Low Expectations
Healthpeak Properties is strategically focused on Class A outpatient and life science real estate, benefiting from demographic tailwinds and supply constraints in key markets. The recent Physicians Realty Trust merger enhances scale, operational synergies, and defensibility, positioning Healthpeak for steady FFO growth as sector fundamentals improve. Despite high leverage and capital allocation risks, Healthpeak trades at a significant discount to historical valuation multiples, offering attractive long-term total return potential.
Healthpeak Properties: Attractive Yield For Income-Oriented Investors
Healthpeak Properties offers strong upside potential, driven by robust AFFO growth, merger synergies, and a well-covered 7% dividend yield. Recent earnings show double-digit revenue and AFFO growth, with management guiding for continued double-digit AFFO growth and solid same-store NOI in 2025. Share repurchases, a switch to monthly dividends, and a healthy balance sheet further support long-term price appreciation and income stability.
Why Healthpeak (DOC) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Healthpeak Offers An Attractive Dividend Yield With Room For Growth
Healthpeak offers a nearly 7% yield, strong dividend coverage, and trades at a deep discount to private market value, making it a compelling buy. The merger with Physicians Realty Trust created a diversified, cost-efficient REIT with reliable income from medical offices and upside from labs and senior housing. Risks like soft lab demand and higher rates are cushioned by long leases, fixed debt, and strong outpatient/CCRC performance, ensuring dividend security.
The Healthpeak Properties Dilemma: Merger Payoff Ahead, Or More Pain For Investors?
DOC is a hold—stock trades near lows, post-merger integration is ongoing, and the market isn't buying the growth story yet. Merger with Physicians Realty Trust brings scale and diversification, but organic growth is lacking and integration risks remain. Valuation isn't compelling: payout ratio is stretched, margins are middling, and peers offer better value or growth opportunities.
Healthpeak: An Attractive Deal Here
Healthpeak Properties is trading at historically low valuations, offering a compelling 7% dividend yield with strong coverage and solid operating results. The REIT's diversified portfolio, consistent NOI growth, and defensive healthcare focus provide stability and resilience against macroeconomic shocks. Insider buying and share repurchases signal management's confidence in the stock's undervaluation and future upside potential.
5 Goldman Sachs S&P 500 Dividend Picks With the Highest Prospective Risk-Adjusted Returns
Founded in 1869, Goldman Sachs is the world's second-largest investment bank by revenue and is ranked 55th on the Fortune 500 list of the largest U.S.
Dividends Under $60: Don't Miss This 7.1% High-Yield Stock
A dividend stock with 7%-plus yields and solid upside potential. The downside risk is also limited at current prices.
